An emerging peptide in the GLP family, studied for its potential to enhance gut-brain signaling, metabolic balance, and nutrient regulation – offering new frontiers in digestive and metabolic research.
For Research Use Only
This product is intended for laboratory research use only (in vitro studies). Not for human or animal consumption, and not for any therapeutic or diagnostic use.
GLP-GIP-Glucagon is a cutting-edge synthetic peptide that combines the actions of GLP-1, GIP, and glucagon receptor agonists. This unique combination allows GLP-GIP-Glucagon to address multiple aspects of metabolic health, including weight management, insulin sensitivity, and cardiovascular health. With a structure comprising multiple amino acids, GLP-GIP-Glucagon’s large molecular size enables it to bind effectively to its target receptors.
GLP-GIP-Glucagon has demonstrated its effectiveness in promoting substantial weight loss, improving insulin sensitivity, and enhancing cardiovascular health. Clinical studies have shown that GLP-GIP-Glucagon can lead to a significant reduction in body weight, improved glucose tolerance, and a decrease in adipose tissue. Additionally, its impact on cardiovascular risk factors highlights its potential as a versatile agent in the management of metabolic health.
Products are lyophilized in powder form.
Justin · Jul 3, 2026
Justin · Jul 3, 2026
Jerry · Jul 2, 2026
Jerry · Jul 2, 2026
BARRY · Jun 6, 2026
Joseph · May 28, 2026
danny · May 25, 2026
